Mapping the HBsAg immune phenotype to predict HBsAg decline in chronic hepatitis B in patients receiving nucleot(s)ide analogue therapy

被引：0
|
作者：
Lim, L. Y. [1 ,2 ]
Yuen, L. [1 ]
Hammond, R. [1 ,2 ]
Angus, P. W.
Thompson, A. J. [1 ,2 ,3 ]
Patterson, S. J.
Leary, T. [4 ]
Yi, P. [4 ]
Thomas, H. [5 ]
Locarnini, S. [1 ]
Walsh, R. [1 ]
机构：
[1] Victorian Infect Dis Reference Lab, Div Mol Res & Dev, North Melbourne, Vic 3051, Australia
[2] Austin Hosp, Dept Gastroenterol, Heidelberg, Vic 3084, Australia
[3] St Vincents Hosp, Dept Gastroenterol, Fitzroy, Vic 3065, Australia
[4] Abbott Labs, Chicago, IL 60064 USA
[5] Univ London Imperial Coll Sci Technol & Med, London, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [21] Mapping HBsAg epitope profiles to predict HBsAg loss/seroconversion in a treatment naive cohort of genotype A chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) therapy
    Walsh, Renae
    Hammond, Rachel
    Yuen, Lilly
    Bayliss, Julianne
    Revill, Peter A.
    Leary, Thomas
    Thomas, Howard
    Gaggar, Anuj
    Subramanian, Mani
    Kitrinos, Kathryn M.
    Thompson, Alex J.
    Locarnini, Stephen
    HEPATOLOGY, 2015, 62 : 966A - 967A
  • [22] FUNCTIONAL IMMUNE RESTORATION CORRELATES WITH HBsAg DECLINE AND MAY PREDICT TREATMENT RESPONSE ON SEQUENTIAL NUC THERAPY IN CHRONIC HEPATITIS B
    Gill, U. S.
    Peppa, D.
    Micco, L.
    Singh, H. D.
    Foster, G. R.
    Maini, M. K.
    Kennedy, P. T.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S496 - S496
  • [23] Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy
    Wang, Meng-Lan
    Chen, En-Qiang
    Tao, Chuan-Min
    Zhou, Tao-You
    Liao, Juan
    Zhang, Dong-Mei
    Wang, Juan
    Tang, Hong
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) : 1420 - 1426
  • [24] Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis
    Hall, Samuel Anthony Lachlan
    Vogrin, Sara
    Wawryk, Olivia
    Burns, Gareth S.
    Visvanathan, Kumar
    Sundararajan, Vijaya
    Thompson, Alexander
    GUT, 2022, 71 (08) : 1629 - 1641
  • [25] FINAL RESULTS OF THE HBV-STOP STUDY - LOW BASELINE HBsAg LEVELS PREDICT DISEASE REMISSION AND HBsAg LOSS AFTER STOPPING NUCLEOT(S)IDE ANALOGUES IN CHRONIC HEPATITIS B E-ANTIGEN NEGATIVE PATIENTS
    Hall, Samuel
    Burns, Gareth
    Anagnostou, Despina
    Vogrin, Sara
    Sundararajan, Vijaya
    Ratnam, Dilip T.
    Levy, Miriam T.
    Lubel, John S.
    Nicoll, Amanda J.
    Strasser, Simone I.
    Sievert, William
    Desmond, Paul V.
    Ngu, Meng Chong
    Angus, Peter W.
    Maree, Sinclair
    Meredith, Christopher
    Matthews, Gail
    Revill, Peter
    Jackson, Kathy
    Bonanzinga, Sara
    Canchola, Jesse
    Kuchta, Alison
    Torres, Jason
    Bowden, Scott
    Locarnini, Stephen
    Visvanathan, Kumar
    Thompson, Alexander
    HEPATOLOGY, 2021, 74 : 482A - 483A
  • [26] Low baseline HBsAg levels predict disease remission and HBsAg loss after stopping nucleot(s)ide analogs in chronic hepatitis B e-antigen-negative patients: Final results of the HBV-STOP study
    Hall, S.
    Burns, G.
    Anagnostou, D.
    Vogrin, S.
    Sundararajan, V.
    Ratnam, D.
    Levy, M.
    Lubel, J.
    Nicoll, A.
    Strasser, S.
    Sievert, W.
    Desmond, P.
    Ngu, M.
    Angus, P.
    Sinclair, M.
    Meredith, C.
    Matthews, G.
    Revill, P.
    Jackson, K.
    Bowden, S.
    Locarnini, S.
    Visvanathan, K.
    Thompson, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 65 - 65
  • [27] HBSAG DECLINE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH POTENT NUCS
    Moucari, Rami
    Bourliere, Marc
    Ripault, Marie-Pierre
    Castelnou, Corinne
    Mackiewicz, Vincent
    Dauvergne, Agnes
    Kahloun, Asma
    Serfaty, Lawrence
    Halfon, Philippe
    Martinot-Peignoux, Michelle
    Nicolas-Chanoine, Marie-Helene
    Marcellin, Patrick
    HEPATOLOGY, 2009, 50 (04) : 507A - 507A
  • [28] Nucleos(t)ide Analogue Discontinuation is not Associated with Increased Rates of HBsAg Loss in Chronic Hepatitis B
    Chi, Heng
    Hansen, Bettina E.
    Feld, Jordan J.
    Buti, Maria
    Brown, Ashley S.
    Carey, Ivana
    Fasano, Massimo
    Mutimer, David J.
    Deterding, Katja
    van Boemmel, Florian
    Yim, Colina
    de Knegt, Robert J.
    Santantonio, Teresa A.
    Welzel, Tania M.
    Pradat, Pierre
    Petersen, Joerg
    Wedemeyer, Heiner
    Berg, Thomas
    Zoulim, Fabien
    Wong, David K.
    Janssen, Harry L.
    HEPATOLOGY, 2016, 64 : 938A - 939A
  • [29] HIGH RATE OF HBSAG LOSS PREDICTED BY BASELINE HBSAG TITER AND DECLINE ON TREATMENT IN CHRONIC HEPATITIS B PATIENTS RECEIVING PEGYLATED INTERFERON PLUS TENOFOVIR COMBINATION THERAPY
    Marcellin, Patrick
    Martinot-Peignoux, Michelle
    Lapalus, Martine
    Lada, Olivier
    Ripault, Marie-Pierre
    Qian, Zhang
    Boyer, Nathalie
    Asselah, Tarik
    HEPATOLOGY, 2011, 54 : 1010A - 1010A
  • [30] HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection
    Yuen, MF
    Wong, DKH
    Yuan, HJ
    Sum, SM
    Lai, CL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) : 4882 - 4884
12345